Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 15, 2010

Premium

Mark McGowan has been named interim president and CEO of CombiMatrix, effective July 1. McGowan, who is also chairman of CombiMatrix's board of directors, will replace outgoing President and CEO Amit Kumar, who has led the firm for the past decade.

CombiMatrix said that it recently retained Caldwell Partners to lead the search and recruitment of a permanent president and CEO.


Myriad Genetics has elected Heiner Dreismann to serve on its board of directors. Dreismann spent two decades at Roche and served as president and CEO of Roche Molecular Systems, and he currently serves on the boards of several healthcare companies.


Response Genetics has named Michael McNulty as its new chief operating officer. McNulty joins the firm from Agilent Technologies, where he most recently served as general manager of diagnostics. He also previously served as vice president of laboratory operations at Berkeley HeartLab.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more